COMPANY · NIPC 500293023

Boehringer Ingelheim Portugal, Lda

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €198,034,646.24 across 3,508 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameBoehringer Ingelheim Portugal, Lda
NIPC500293023
Registered office1800-294 Portugal
SourceTED (Jornal Oficial da UE), aviso 424218-2025
Record date1 July 2025

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €3,032,225.7420122013: €2,135,515.572014: €24,220,948.8520142015: €20,305,137.252016: €2,381,023.3420162017: €3,010,096.192018: €5,226,369.1620182019: €11,940,473.892020: €11,488,155.1220202021: €9,542,228.302022: €15,869,817.1020222023: €18,367,331.392024: €24,711,617.7520242025: €29,558,676.712026: €16,245,029.882026€29,558,676.71
Contracted value by year
YearContractsContract value
201250€3,032,225.74
201396€2,135,515.57
2014162€24,220,948.85
2015142€20,305,137.25
2016134€2,381,023.34
2017187€3,010,096.19
2018212€5,226,369.16
2019317€11,940,473.89
2020331€11,488,155.12
2021319€9,542,228.30
2022298€15,869,817.10
2023318€18,367,331.39
2024375€24,711,617.75
2025328€29,558,676.71
2026239€16,245,029.88
Contracted value by place of performance
NameContractsContract value
Coimbra159€43,449,011.29
Faro240€26,668,366.09
Lisboa562€18,982,116.17
Porto241€8,751,320.48
Évora95€7,585,557.03
Setúbal70€7,209,634.74
Vila Nova de Gaia152€7,147,437.58
Amadora91€5,000,736.15
Viana do Castelo58€4,443,671.45
Almada160€4,373,899.53
Largest contracts
SubjectYearContract value
Medicamentos anti-infecciosos e antiretrovirais - c/ base no CPA 2013/402015€12,763,207.62
Medicamentos anti-infecciosos, anti-retrovirais2014€11,663,507.38
41/9061/2026 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0304 - Medicamentos do grupo 4: sangue; 2023/0437 - Medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicaçõ2026€4,281,799.44
Medicamentos de consumo geral grupo 4 - sangue - C/ Base no CPA 2014/182015€4,094,676.76
Medicamentos do grupo 4 - sangue2014€3,744,030.91

Who they competed with

In 8,717 contracts with a list of competitors, the company took part and was awarded 1,164 (13%).

Companies with the most procedures in common
CompanyProcedures in common
generis525
mylan399
sandoz farmaceutica390
medinfar383
labesfal,, SA358
overpharma355
farmoz, sa349
accord healthcare unipessoal, lda322
b.braun medical312
astrazeneca233
fresenius kabi pharma227
teva226
hikma lda217
pfizer212
glaxo204
Novartis, S.A.191
bAYER151
angelini143
PLS Pharma, Produtos Farmacêuticos, Lda137
Bluepharma, S.A.119
logifarma116
grunenthal114
DLA-Farmacêutica,SA.112
roche110
sidefarma lda109
Zentiva, Lda.109
pharmakern portugal108
janssen105
leo103
korangi100

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents40 companies and 60 links. The list below gives the same content as text.bAYER (NIPC 500043256)bAYERNovartis, S.A. (NIPC 500063524)Novartis, S.A.glaxo (NIPC 500139962)glaxopfizer (NIPC 500162166)pfizerjanssen (NIPC 500189412)janssenroche (NIPC 500233810)rocheBoehringer Ingelheim Port… (NIPC 500293023)Boehringer Ingelheim Port…medinfar (NIPC 500384045)medinfarangelini (NIPC 500583650)angelinilabesfal,, SA (NIPC 501169580)labesfal,, SAfarmoz, sa (NIPC 501505334)farmoz, sa+29 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.